-
California system taps specialty pharmacy partner
Sharp HealthCare, a seven-hospital system in San Diego, partnered with a specialty pharmacy solutions provider Jan. 30. -
FDA sets end date for Paxlovid emergency use
The FDA will end emergency use authorization of Paxlovid for adult patients March 8. -
OTC morning-after pill tied to 96% fewer related ED visits
After the FDA approved the first over-the-counter emergency contraception in 2006, emergency department visits for the medication decreased by 96% over the next 14 years, according to a new study. -
Weight loss drugs show strides in reducing inflammation
A new class of weight loss and diabetes drugs could reduce inflammation in the liver, kidneys, heart and even the brain, Nature reported Jan. 26. -
Novo Nordisk to stop selling Levemir insulin
Levemir, one of the three types of long-acting basal insulins, is evacuating the U.S. market, and diabetes patient advocates told USA Today they're worried about using a new medication after nearly two decades. -
FDA clears Dupixent to treat esophageal condition in kids under 12
The FDA has given the green light to Sanofi's drug Dupixent to be used as treatment in pediatric patients with chronic eosinophilic esophagitis, the pharmaceutical company announced Jan. 25. -
Baptist Health nears completion of $40M central pharmacy
Baptist Health's central pharmacy center is months away from filling up to 14,000 prescriptions a day, and the facility will be the nation's most automated central pharmacy. -
Walgreens, Vermont reach settlement over claims of unsafe pharmacy conditions
Walgreens has reached a $275,000 settlement with the state of Vermont over allegations that medication and vaccination errors and other alleged violations created unsafe conditions for patients and staff at the chain's pharmacies across the state. -
Popular cough syrup recalled over contamination
Haleon, the maker of Robitussin, has issued a voluntary recall of eight lots of three varieties of its cough medicines due to microbial contamination. -
Fake Ozempic tied to 3 cases of hypoglycemia: Reuters
A regional poison control center suspects three cases of hypoglycemia in 2023 were linked to counterfeit versions of Ozempic, according to a Jan. 24 Reuters exclusive report. -
Judge upholds Martin Shkreli's lifetime pharma ban
A federal appeals court in New York has upheld an order that bars "pharma bro" Martin Shkreli from working in the pharmaceutical industry, according to court documents. -
Tyson replaces CVS with Rightway for pharmacy benefits
CVS Caremark will no longer handle pharmacy costs for Tyson Foods' 140,000 employees after the company cut its contract, CNBC reported Jan. 24. A few months ago, Blue Shield California curbed its yearslong partnership with the pharmacy benefit manager. -
Majority of patients maintain weight loss after stopping medication, study reveals
After discontinuing the use of semaglutide and liraglutide weight-loss medications, a majority of patients were able to maintain the same weight they were at when halting the use — or even continued to lose additional weight after one year, a new study revealed. -
How the Ozempic boom affects hospital pharmacies
The viral popularity of Ozempic, Wegovy, and other diabetes and weight loss drugs is affecting hospital operations in a roundabout way. -
FDA calls for warning labels on commercial CAR-T therapies amid cancer probe
The FDA is now calling for warning labels on all commercial CAR-T therapy products amid its investigation into 22 reports about a possible being linked to lymphoma. -
Corrections made in ongoing FDA eye drop recall
The FDA has published corrections and additions to a company's voluntary recall of eye drops after a wave of several others throughout 2023. -
Washington pharmacists prepare to prescribe abortion pills
A handful of pharmacists in Washington state are training to prescribe the abortion medication mifepristone, NPR reported Jan. 22. -
Maryland system reduces opioid scripts by 55%
Over the last five years, Hagerstown, Md.-based Meritus Health cut the number of opiates prescribed by more than 55% in its effort to quell the national opioid epidemic. -
Drug shortages group elects 3 pharmacy leaders to board
The End Drug Shortages Alliance appointed Terri Lyle Wilson as its new chair and appointed two board members Jan. 23. -
North Carolina state health plan drops weight loss drug coverage; to incur $54M rebate loss
North Carolina's state health plan dropped new coverage for weight loss drugs Jan. 1, a decision that is expected to cost the state $54 million in lost drug rebates, WRAL News reported Jan. 12.
Page 10 of 50